QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin
- 1 September 2002
- journal article
- case report
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 23 (5) , 303-307
- https://doi.org/10.1053/ajot.2002.124543
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Risk Assessment for Antimicrobial Agent‐Induced QTc Interval Prolongation and Torsades de PointesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Safety of Antihistamines in ChildrenDrug Safety, 2001
- Macrolide Treatment Decreased the Size of Nasal Polyps and IL-8 Levels in Nasal LavageAmerican Journal of Rhinology, 2000
- Quinolone-induced QT interval prolongation: a not-so-unexpected class effectJournal of Antimicrobial Chemotherapy, 2000
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Arrhythmogenic mechanisms of non‐sedating antihistaminesClinical and Experimental Allergy, 1999
- The Effects of Erythromycin on the ElectrocardiogramChest, 1999
- QT Prolongation and Torsades de Pointes Associated with ClarithromycinThe American Journal of Medicine, 1998
- Multiple Mechanisms in the Long-QT SyndromeCirculation, 1996
- How to measure the QT interval—What is normal?The American Journal of Cardiology, 1993